What is Rubi Laboratories?
Rubi Laboratories operates at the intersection of synthetic biology and industrial manufacturing, specializing in the conversion of carbon emissions into high-performance biobased textiles. By utilizing advanced enzymatic processes, the company effectively captures carbon dioxide and transforms it into cellulose, offering a sustainable alternative to traditional, resource-intensive fabric production. This approach not only addresses the environmental footprint of the apparel sector but also provides a scalable, traceable solution for brands seeking to achieve net-zero targets. As a leader in the circular economy, Rubi Laboratories is redefining material science by turning a primary climate pollutant into a valuable, planet-positive commodity.
How much funding has Rubi Laboratories raised?
Rubi Laboratories has raised a total of $21M across 2 funding rounds:
Angel/Seed
$13.5M
Unspecified
$7.5M
Angel/Seed (2023): $13.5M with participation from Necessary Ventures, Tin Shed Ventures, H&M Group, Collaborative Fund, and Talis Capital
Unspecified (2026): $7.5M led by AP Ventures, H&M Group, Talis Capital, FH One, and CMPC Ventures
Key Investors in Rubi Laboratories
AP Ventures
A London-based venture capital firm specializing in high-growth technology companies within the hydrogen value chain and broader decarbonization sectors.
H&M Group
A multinational clothing-retail leader headquartered in Sweden, actively investing in sustainable innovations to improve the environmental impact of its global supply chain.
Talis Capital
A high-conviction investment firm focused on supporting innovative entrepreneurs at the Seed and Series A stages across Europe and the United States.
What's next for Rubi Laboratories?
With the recent influx of capital, Rubi Laboratories is poised to accelerate its commercialization roadmap, focusing on the expansion of its manufacturing infrastructure and the optimization of its enzymatic carbon-capture systems. The strategic nature of this investment suggests a move toward deeper integration with global apparel supply chains, likely involving pilot programs with major retail partners to validate the scalability of its biobased materials. Moving forward, the company will likely prioritize the refinement of its production efficiency to achieve cost parity with conventional textiles, a critical step for widespread market adoption. By leveraging its robust network of strategic investors, Rubi Laboratories is set to solidify its position as a cornerstone of the next generation of sustainable industrial technology.
See full Rubi Laboratories company page
